Jonathan Jensen, MD
Urology · Wichita, KSNPI 1760825137
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations.
Across 153 payments — averaging $23.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$443
- Johnson & Johnson$389
- Boston Scientific$249
- Olympus America Inc.$188
- Axonics, Inc.$163
- Medtronic$161
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,43495%
- Education$1755%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 27 | $443 |
| Johnson & Johnson | 20 | $389 |
| Boston Scientific | 4 | $249 |
| Olympus America Inc. | 8 | $188 |
| Axonics, Inc. | 4 | $163 |
| Medtronic | 3 | $161 |
| Bayer | 6 | $152 |
| Pfizer | 9 | $151 |
| Laborie Medical Technologies Corp. | 2 | $145 |
| Dendreon Pharmaceuticals LLC | 6 | $129 |
| AbbVie(2 entities) | 8 | $126 |
| Travere Therapeutics, Inc. | 6 | $109 |
| Sumitomo Pharma America, Inc. | 5 | $105 |
| Endo Pharmaceuticals Inc. | 1 | $98 |
| Myovant Sciences Inc. | 1 | $93 |
| Procept Biorobotics Corporation | 1 | $91 |
| Merck | 5 | $90 |
| Blue Earth Diagnostics | 5 | $76 |
| Tolmar Pharmaceuticals, Inc. | 5 | $74 |
| Janssen Scientific Affairs, LLC | 1 | $71 |
| Coloplast | 5 | $70 |
| Calyxo, Inc. | 3 | $62 |
| Urogen Pharma, Inc. | 4 | $62 |
| Progenics Pharmaceuticals, Inc. | 2 | $50 |
| Myriad Genetic Laboratories, Inc. | 2 | $50 |
| Siemens Medical Solutions USA, Inc. | 1 | $38 |
| Sanofi | 1 | $28 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $25 |
| Teleflex LLC | 1 | $21 |
| 180 Medical, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $16 |
| Telix Pharmaceuticals | 1 | $16 |
| ABC Home Medical Supply, Inc. | 1 | $15 |
| BD | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optilume BPH Drug Coated Balloon Catheter$112
- AMS$112
- Axonics$111
- LithoVue$108
How this compares
$3,609 in reported general payments places this provider in the 60th percentile of 111 urology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 51 | $733,535 |
| NubeqaDarolutamide | 33 | $408,485 |
| XtandiEnzalutamide | 22 | $318,038 |
| OrgovyxRelugolix | 106 | $279,274 |
| MyrbetriqMirabegron | 43 | $23,052 |
| GemtesaVibegron | 20 | $9,190 |
| Tamsulosin Hcl | 1,004 | $6,995 |
| Solifenacin Succinate | 176 | $6,698 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 21 | $1,336 |
| Estradiol | 16 | $1,243 |
| Oxybutynin Chloride | 72 | $789 |
| Testosterone Cypionate | 21 | $677 |
| Oxybutynin Chloride ErOxybutynin Chloride | 39 | $612 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 151 | $518 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 31 | $434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $389 | $733,53551 claims |
| BayerNubeqa | $152 | $408,48533 claims |
| Astellas Pharma US IncXtandi, Myrbetriq | $443 | $341,09165 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $105 | $288,464126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 111 urology providers in Kansas.
Other urology in Wichita
- Timothy RichardsonWichita$493K
- Gregory ByrdWichita$18K
- Philippe NabboutWichita$13K
- Fadi JoudiWichita$12K
- Ayham FarhaWichita$8K
- Jeffrey DavisWichita$8K
- James GilbaughWichita$5K
- George ZakhariaWichita$3K
- Surendra KollaWichita$3K
- Kahlil SaadWichita$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.